What is AIQ Solutions?
AIQ Solutions develops advanced medical software technology designed for early-stage drug development by pharmaceutical companies and patient therapy optimization within hospital systems. The company's proprietary software offers critical intelligence on oncology treatment effectiveness and toxicity risk by analyzing imaging data to measure treatment response heterogeneity, thereby predicting patient outcomes. Based in Madison, WI, AIQ Solutions is positioned at the intersection of healthcare technology and data analytics, providing crucial insights for complex medical decisions.
How much funding has AIQ Solutions raised?
AIQ Solutions has raised a total of $3.2M across 1 funding round:
Series A
$3.2M
Series A (2019): $3.2M with participation from Capital Midwest Fund, Rock River Capital Partners, 30Ventures, and Wisconsin Investment Partners
Key Investors in AIQ Solutions
Capital Midwest Fund
Capital Midwest Fund (CMF) invests in revenue-stage companies in the Central United States that provide technology solutions, including software, services, and products, primarily targeting industrial, manufacturing, and enterprise customers. The fund focuses on companies with management that understands trending technology themes and has effectively applied this knowledge to address specific customer challenges. CMF seeks businesses that have demonstrated market acceptance and traction in their respective fields.
Rock River Capital Partners
Undisclosed investor participating in the funding round.
Wisconsin Investment Partners
Wisconsin Investment Partners (WIP) is a prominent angel investment group and business incubator based in Wisconsin. The organization focuses on providing funding and support to entrepreneurs seeking investment for their ventures. WIP also offers membership opportunities for investors interested in joining their network. With a strong portfolio and a commitment to fostering innovation, WIP aims to drive growth in the entrepreneurial ecosystem.
What's next for AIQ Solutions?
The recent major strategic investment signifies a pivotal moment for AIQ Solutions, likely enabling the company to accelerate its product development, expand its market reach, and further enhance its analytical capabilities in oncology and patient therapy. This capital infusion is expected to fuel growth and solidify its position as a key player in medical software, particularly in areas requiring sophisticated data analysis for treatment efficacy and risk assessment.
See full AIQ Solutions company page
